Research on the Role of SLC1A5 in the Development of Esophageal Cancer
NCT ID: NCT02633436
Last Updated: 2016-08-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
100 participants
OBSERVATIONAL
2015-12-31
2018-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
China Early Esophageal Cancer Cohort
NCT06515964
Perioperative Vs. Preoperative Chemotherapy With Surgery in the Squamous Carcinoma of Esophagus
NCT01225523
Characteristics and Tumor Staging Proposal for Primary Malignant Melanoma of the Esophagus
NCT06291753
Outcomes of A Novel Treatment Decision of Patients With Esophageal and Head and Neck Carcinoma Synchronously
NCT03450447
Long-term Outcomes of Superficial Esophageal Squamous Cell Carcinoma
NCT02908204
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The investigators will be using a standardized data collection form. This is an observational study in which standard of care will be practiced and the patients are not placed at additional risk from participating in this study. However, as the investigators are collecting data prospectively, all participants will sign consent. An attempt will be made to see if there is a correlation between the expression of SLC1A5 with esophageal cancer.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
cancer tissues
SLC1A5 expression of esophageal cancer tissues from patients
SLC1A5 expression
To observe the expression of SLC1A5 by immunohistochemistry and WesternBlot analysis.
paired adjacent tissues
SLC1A5 expression of paired adjacent esophageal tissues from patients
SLC1A5 expression
To observe the expression of SLC1A5 by immunohistochemistry and WesternBlot analysis.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
SLC1A5 expression
To observe the expression of SLC1A5 by immunohistochemistry and WesternBlot analysis.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Age ≥18 years;
3. All patients must sign consent forms voluntarily;
Exclusion Criteria
2. Age \<18 years;
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Liuzhou Maternity and Child Healthcare Hospital
OTHER
Fourth Affiliated Hospital of Guangxi Medical University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Xiangcheng Wei
Role: PRINCIPAL_INVESTIGATOR
Guangxi Medical University Institutional Review Board
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Liuzhou Maternity and Child Healthcare Hospital
Liuzhou, Guangxi, China
The Fourth Affiliated Hospital of Guangxi Medical University
Liuzhou, Guangxi, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PJK201518
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.